GEMTESA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Urovant Sciences, Inc.. The primary component is Vibegron.
| Product ID | 73336-075_1dc55414-952a-420f-9cfb-8eb776917946 |
| NDC | 73336-075 |
| Product Type | Human Prescription Drug |
| Proprietary Name | GEMTESA |
| Generic Name | Vibegron |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-12-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213006 |
| Labeler Name | Urovant Sciences, Inc. |
| Substance Name | VIBEGRON |
| Active Ingredient Strength | 75 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-12-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GEMTESA 79329263 not registered Live/Pending |
Urovant Sciences GmbH 2021-10-25 |
![]() GEMTESA 79246577 not registered Live/Pending |
Urovant Sciences GmbH 2018-11-01 |